Johnson & Johnson (BSP:JNJB34)
R$ 60.12 0 (0%) Market Cap: 2.18 Til Enterprise Value: 2.27 Til PE Ratio: 24.52 PB Ratio: 5.08 GF Score: 76/100

Johnson & Johnson at Bank of America Healthcare Conference Transcript

May 11, 2022 / 07:40PM GMT
Release Date Price: R$60.62 (+0.33%)
Travis Lee Steed
BofA Securities, Research Division - MD

I'm Travis Steed, medical device analyst, and also have Geoff Meacham from BofA. He's technically the lead coverage on J&J, and I co-cover the device business with him. And we also have Ashley McEvoy, Head of Medical Devices for J&J. So welcome to Vegas. Thank you.

Ashley A. McEvoy
Johnson & Johnson - Executive VP & Worldwide Chairman of MedTech

Thanks. It's good to be here, Travis. Good to be here, Geoff. Welcome, everyone. Good to see people in person. Human beings, we're a social species. We like to see each other, talk to each other. It's good for health care after this conference. Health care will be booming.

Questions & Answers

Travis Lee Steed
BofA Securities, Research Division - MD

Exactly. I guess I just wanted to start, Ashley, with kind of a bigger picture question. Looking at J&J on a historical basis, like there was a lot of markets that J&J missed out on that ended up being big growth markets and kind of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot